Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Bonus Jun 12, 2000 Jun 28, 2000 May 25, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus--Jul 25, 1977 Bonus Ratio: 4 share(s) for every 5 shares held Bonus--Jul 25, 1972 Bonus Ratio: 2 ...

Moderna MRNA incurred a loss of $2.50 per share in the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of ...

The company granted stock options to purchase an aggregate of 208,350 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 272,850 shares of Nurix common ...

PORTLAND, OR, UNITED STATES, February 15, 2025 /EINPresswire / -- Ankylosing spondylitis (AS) is a chronic inf ...